Cargando…
Investigating the Relationship between Serum Level of s-Met (Soluble Hepatic Growth Factor Receptor) and Preeclampsia in the First and Second Trimesters of Pregnancy
Introduction. Preeclampsia (PE) is an important cause of mortality and morbidity for mothers, fetuses, and the newborns. Placenta plays a pivotal role in pathogenesis of PE. Hepatic growth factor (HGF) is a cytokine expressed by the mesenchymal stalk of placental villi during pregnancy and assumes a...
Autores principales: | Naghshvar, Farshad, Torabizadeh, Zhila, Moslemi Zadeh, Narges, Mirbaha, Hooman, Gheshlaghi, Parand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747406/ https://www.ncbi.nlm.nih.gov/pubmed/23984083 http://dx.doi.org/10.1155/2013/925062 |
Ejemplares similares
-
PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?
por: Moslemi Zadeh, Narges, et al.
Publicado: (2012) -
Immunohistochemical Expression of Nanog and Its Relation with Clinicopathologic Characteristics in Breast Ductal Carcinoma
por: Saravi, Omid Emadian, et al.
Publicado: (2019) -
“Abnormal Analyte Preeclampsia”: Do the second trimester maternal serum analytes help differentiate preeclampsia subtypes?
por: CRITCHFIELD, Agatha S, et al.
Publicado: (2013) -
Differences in maternal soluble ST2 levels in the third trimester of normal pregnancy versus preeclampsia
por: Sasmaya, Prameswari Hawani, et al.
Publicado: (2021) -
Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters
por: Wang, Jing, et al.
Publicado: (2020)